In prostate cancer, sTn is detected in up to half of all high grade tumours [12,13], and sTn-MUC1 has been correlated with survival outcome and higher serum Prostate Specific Antigen (PSA) levels [55]. The gene discussed is KLK3; the disease is prostate cancer.